Texas Yale Capital Corp’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $320K | Hold |
2,085
| – | – | 0.01% | 392 |
|
|
2025
Q1 | $328K | Hold |
2,085
| – | – | 0.01% | 377 |
|
|
2024
Q4 | $327K | Buy |
2,085
+360
| +21% | +$56.5K | 0.01% | 380 |
|
|
2024
Q3 | $306K | Hold |
1,725
| – | – | 0.01% | 389 |
|
|
2024
Q2 | $291K | Hold |
1,725
| – | – | 0.01% | 377 |
|
|
2024
Q1 | $287K | Hold |
1,725
| – | – | 0.01% | 385 |
|
|
2023
Q4 | $285K | Hold |
1,725
| – | – | 0.01% | 377 |
|
|
2023
Q3 | $269K | Hold |
1,725
| – | – | 0.01% | 370 |
|
|
2023
Q2 | $269K | Hold |
1,725
| – | – | 0.01% | 382 |
|
|
2023
Q1 | $280K | Hold |
1,725
| – | – | 0.01% | 385 |
|
|
2022
Q4 | $276K | Hold |
1,725
| – | – | 0.02% | 386 |
|
|
2022
Q3 | $243K | Hold |
1,725
| – | – | 0.02% | 388 |
|
|
2022
Q2 | $251K | Buy |
+1,725
| New | +$251K | 0.02% | 385 |
|